Sickle Cell Disease Treatment Market by Indication and Geography - Forecast and Analysis 2021-2025

***1. Executive Summary                           

                **1.1     Market Overview            

                                *Exhibit 01:  Key Finding 1

                                *Exhibit 02:  Key Finding 2

                                *Exhibit 03:  Key Finding 3

                                *Exhibit 04:  Key Finding 5

                                *Exhibit 05:  Key Finding 6

                                *Exhibit 06:  Key Finding 7

                                *Exhibit 07:  Key Finding 8

***2. Market Landscape             

             **2.1 Market ecosystem

                                *2.1.1 Parent Market

                                *Exhibit 08:  Parent market

                                *Exhibit 09:  Market characteristics

                **2.2 Value Chain Analysis          

                                *Exhibit 10:  Value Chain Analysis: Pharmaceuticals

                                *2.2.1    Research and development (R&D) and drug discovery

                                *2.2.2    Integration and product development

                                *2.2.3    Manufacturing

                                *2.2.4    Outbound logistics

                                *2.2.5    Marketing and sales

                                *2.2.6    Support services

                             *2.2.7   Innovation

***3. Market Sizing                       

                **3.1 Market definition

                                *Exhibit 11:  Offerings of vendors included in the market definition

                **3.2 Market segment analysis 

                                *Exhibit 12:  Market segments

                **3.3 Market size 2021 

                **3.4 Market outlook: Forecast for 2020 - 2025 

                                *3.4.1Estimating growth rates for emerging and high-growth markets

                                *3.4.2Estimating growth rates for mature markets

                                *Exhibit 13:  Global - Market size and forecast 2020 - 2025 ($ million)

                                *Exhibit 14:  Global market: Year-over-year growth 2020 - 2025 (%)

***4. Five Forces Analysis                          

                **4.1 Five Forces Summary        

                                *Exhibit 15:  Five forces analysis 2020 & 2025

                **4.2 Bargaining power of buyers           

                                *Exhibit 16: Bargaining power of the buyer

                **4.3 Bargaining power of suppliers       

                                *Exhibit 17: Bargaining power of the supplier

                **4.4 Threat of new entrants    

                                *Exhibit 18: Threat of new entrants

                **4.5 Threat of substitutes         

                                *Exhibit 19: Threat of substitutes

                **4.6 Threat of rivalry   

                                *Exhibit 20: Threat of rivalry

                **4.7 Market condition

                                *Exhibit 21: Market condition - Five forces 2020

***5. Market Segmentation by Indication          

              **5.1 Market segments

                                *Exhibit 22:  Indication- Market share 2020-2025 (%)

                **5.2 Comparison by Indication

                                *Exhibit 23:  Comparison by Indication

                **5.3 Sickle cell anemia - Market size and forecast 2020-2025      

                                *Exhibit 24:  Sickle cell anemia - Market size and forecast 2020-2025 ($ million)

                                *Exhibit 25:  Sickle cell anemia - Year-over-year growth 2020-2025 (%)

                **5.4 Sickle beta thalassemia  - Market size and forecast 2020-2025         

                                *Exhibit 26:  Sickle beta thalassemia  - Market size and forecast 2020-2025 ($ million)

                                *Exhibit 27:  Sickle beta thalassemia  - Year-over-year growth 2020-2025 (%)

                **5.5 Others - Market size and forecast 2020-2025           

                                *Exhibit 28:  Others - Market size and forecast 2020-2025 ($ million)

                                *Exhibit 29:  Others - Year-over-year growth 2020-2025 (%)

                **5.6 Market opportunity by Indication

                                *Exhibit 30:  Market opportunity by Indication

***6. Customer landscape                         

                                *Technavio’s customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria

                **6.1 Overview

                                *Exhibit 31:  Customer landscape

***7. Geographic Landscape                     

                **7.1 Geographic segmentation

                                *Exhibit 32:  Market share by geography 2020-2025 (%)

                **7.2 Geographic comparison   

                                *Exhibit 33:  Geographic comparison

                **7.3 North America - Market size and forecast 2020-2025           

                                *Exhibit 34:  North America - Market size and forecast 2020-2025 ($ million)

                                *Exhibit 35:  North America - Year-over-year growth 2020-2025 (%)

                **7.4 Europe - Market size and forecast 2020-2025          

                                *Exhibit 36:  Europe - Market size and forecast 2020-2025 ($ million)

                                *Exhibit 37:  Europe - Year-over-year growth 2020-2025 (%)

                **7.5 Asia - Market size and forecast 2020-2025

                                *Exhibit 38:  Asia - Market size and forecast 2020-2025 ($ million)

                                *Exhibit 39:  Asia - Year-over-year growth 2020-2025 (%)

                **7.6 ROW- Market size and forecast 2020-2025               

                                *Exhibit 40:  ROW - Market size and forecast 2020-2025 ($ million)

                                *Exhibit 41:  ROW - Year-over-year growth 2020-2025 (%)

                **7.7 Key leading countries        

                                *Exhibit 42:  Key leading countries

                **7.8 Market opportunity by geography

                                *Exhibit 43:  Market opportunity by geography ($ million)

***8. Drivers, Challenges, and Trends                   

                **8.1 Market drivers     

                                *8.1.1    High prevalence of sickle cell disease

                                *8.1.2    Provision of special drug designations

                                *8.1.3    Increase in screening tests on infants

                **8.2 Market challenges              

                                *8.2.1    High cost of treatment

                                *8.2.2    Lack of approved therapies

                                *8.2.3    Stringent regulatory policies

                                *Exhibit 44:  Impact of drivers and challenges

                **8.3 Market trends      

                                *8.3.1    Strong pipeline

                                *8.3.2    Advent of regenerative therapy

                                *8.3.3    New treatments

***9. Vendor Landscape                             

                **9.1 Overview

                                *Exhibit 45:  Vendor landscape

                **9.2 Landscape disruption        

                                *Exhibit 46:  Landscape disruption

                                *Exhibit 47: Industry Risk

                **9.3 Competitive Scenario        

***10. Vendor Analysis               

                **10.1 Vendors covered              

                                *Exhibit 48: Vendors covered

                **10.2 Market positioning of vendors    

                                *Exhibit 49: ?Market positioning of vendors?

                **10.3 Addmedica SAS 

                                *Exhibit 50:  Addmedica SAS - Overview

                                *Exhibit 51:  Addmedica SAS - Product and service

                                *Exhibit 52:  Addmedica SAS - Key offerings

                **10.4 Bristol-Myers Squibb Co.

                                *Exhibit 53:  Bristol-Myers Squibb Co. - Overview

                                *Exhibit 54:  Bristol-Myers Squibb Co. - Product and service

                                *Exhibit 55:  Bristol-Myers Squibb Co. - Key offerings

                **10.5 Chiesi Pharmaceuticals BV            

                                *Exhibit 56:  Chiesi Pharmaceuticals BV - Overview

                                *Exhibit 57:  Chiesi Pharmaceuticals BV - Product and service

                                *Exhibit 58:  Chiesi Pharmaceuticals BV - Key offerings

                **10.6 CRISPR Therapeutics AG

                                *Exhibit 59:  CRISPR Therapeutics AG - Overview

                                *Exhibit 60:  CRISPR Therapeutics AG - Business segments

                                *Exhibit 61:  CRISPR Therapeutics AG - Key offerings

                                *Exhibit 62:  CRISPR Therapeutics AG - Segment focus

                **10.7 Emmaus Life Sciences Inc.             

                                *Exhibit 63:  Emmaus Life Sciences Inc. - Overview

                                *Exhibit 64:  Emmaus Life Sciences Inc. - Business segments

                                *Exhibit 65:  Emmaus Life Sciences Inc. - Key offerings

                                *Exhibit 66:  Emmaus Life Sciences Inc. - Segment focus

                **10.8 Global Blood Therapeutics Inc.   

                                *Exhibit 67:  Global Blood Therapeutics Inc. - Overview

                                *Exhibit 68:  Global Blood Therapeutics Inc. - Business segments

                                *Exhibit 69:  Global Blood Therapeutics Inc. - Key offerings

                                *Exhibit 70:  Global Blood Therapeutics Inc. - Segment focus

                **10.9 GlycoMimetics Inc.          

                                *Exhibit 71:  GlycoMimetics Inc. - Overview

                                *Exhibit 72:  GlycoMimetics Inc. - Business segments

                                *Exhibit 73:  GlycoMimetics Inc. - Key offerings

                                *Exhibit 74:  GlycoMimetics Inc. - Segment focus

                **10.10 Medunik USA  

                                *Exhibit 75:  Medunik USA - Overview

                                *Exhibit 76:  Medunik USA - Product and service

                                *Exhibit 77:  Medunik USA - Key offerings

                **10.11 Novartis AG      

                                *Exhibit 78:  Novartis AG - Overview

                                *Exhibit 79:  Novartis AG - Business segments

                                *Exhibit 80:  Novartis AG - Key offerings

                                *Exhibit 81:  Novartis AG - Segment focus

                **10.12 Pfizer Inc.          

                                *Exhibit 82:  Pfizer Inc. - Overview

                                *Exhibit 83:  Pfizer Inc. - Business segments

                                *Exhibit 84:  Pfizer Inc. - Key offerings

                                *Exhibit 85:  Pfizer Inc. - Segment focus

***11. Appendix                            

                **11.1 Scope of the report         

                                *11.1.1 ????Market definition

                                *11.1.2 ????Objectives

                                *11.1.3 ????Notes and caveats

                **11.2 Currency conversion rates for US$            

                                *Exhibit 86: ?Currency conversion rates for US$?

                **11.3 Research Methodology 

                                *Exhibit 87: ?Research Methodology

                                *Exhibit 88: ??Validation techniques employed for market sizing?

                                *Exhibit 89: ??Information sources

                **11.4 List of abbreviations        

                                *Exhibit 90: List of abbreviations